Cart
sales@molnova.com
PTP Inhibitor II
CAS No. 2632-13-5
PTP Inhibitor II ( —— )
Catalog No. M20862 CAS No. 2632-13-5
PTP inhibitor II is an ?inhibitor of cell-permeable protein tyrosine phosphatase (PTP) that covalently binds the catalytic domain of the Src homology region 2 domain-containing phosphatase (SHP-1(ΔSH2))with Ki of128 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 29 | Get Quote |
|
| 100MG | 41 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePTP Inhibitor II
-
NoteResearch use only not for human use.
-
Brief DescriptionPTP inhibitor II is an ?inhibitor of cell-permeable protein tyrosine phosphatase (PTP) that covalently binds the catalytic domain of the Src homology region 2 domain-containing phosphatase (SHP-1(ΔSH2))with Ki of128 μM.
-
DescriptionPTP inhibitor II is an ?inhibitor of cell-permeable protein tyrosine phosphatase (PTP) that covalently binds the catalytic domain of the Src homology region 2 domain-containing phosphatase (SHP-1(ΔSH2))with Ki of128 μM.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPhosphatase
-
Recptorprotein tyrosine phosphatase(PTP)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2632-13-5
-
Formula Weight229.07
-
Molecular FormulaC9H9BrO2
-
Purity>98% (HPLC)
-
SolubilityDMSO:45mg/mL(196.45mM)
-
SMILESCOc1ccc(C(=O)CBr)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Arabaci G Guo X C Beebe K D et al. α-Haloacetophenone Derivatives As Photoreversible Covalent Inhibitors of Protein Tyrosine Phosphatases[J]. Journal of the American Chemical Society 1999 121(21):5085-5086.
molnova catalog
related products
-
Raphin1 acetate
Raphin1 acetate is a selective and orally bioavailable regulatory phosphatase PPP1R15B (R15B) inhibitor.Raphin1, a selective inhibitor of R15B.?In cells, Raphin1 caused a rapid and transient accumulation of its phosphorylated substrate, resulting in a transient attenuation of protein synthesis.?
-
TNO155
TNO155 is a protein tyrosine phosphatase (PTP) non-receptor type 11 (SHP2; src homology region 2 domain phosphatase; PTPN11) inhibitor(IC50 : 0.011 μM),with potential antineoplastic activity.
-
BCI
BCI is an allosteric inhibitor of dual-specificity phosphatase (DUSP; EC50s: 13.3 and 8.0 μM for DUSP6 and DUSP1 in cells) and does not inhibit DUSP5.
